Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
· Equinix appointed former Vocus executive Jarrod Nink as its new managing director for Australia. · Following the executive announcement, Equinix shares traded higher at US$1,084.24. · The leadership ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Ora Banda Mining (ASX:OBM) has reported significant high-grade drill results at its Waihi Project, with targeted follow-up drilling on the Golden Pole Lode continuing to expand the mineralised ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances. Grafa is not liable for any loss caused, whether due ...
Mesoblast shares were in focus Monday after the company announced positive formal feedback from the U.S. Food and Drug Administration (FDA) regarding its allogeneic cell therapy, rexlemestrocel-L. The ...
Gilead Sciences (NASDAQ:GILD) announced the deployment of an initial emergency donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results